Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Michael Metzger Insider Profile
4 Followers
Michael Metzger, President & CEO, Director at Tobira Therapeutics, holds 0.00 shares in Tobira Therapeutics (Ticker: TBRA), holds 0.00 shares in CTI BioPharma (Ticker: CTIC), holds 17.66K shares in Syndax Pharmaceuticals (Ticker: SNDX). Most recently, Michael Metzger ― shares of Tobira Therapeutics on ― for an estimated value of ―.
Michael Metzger Tobira Therapeutics (TBRA)President & CEO, Director
Tobira Therapeutics (TBRA)
President & CEO, Director
Not Ranked
Michael Metzger has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Michael Metzger holds in companies
Most Profitable Insider Trade
The most profitable trade made by Michael Metzger
Michael Metzger's Trading History
Tobira Therapeutics
―
―
―
$0.00
CTI BioPharma
―
Director
―
$0.00
Syndax Pharmaceuticals
Nov 06, 2020
President & COO, Director
Uninformative Sell
2.03M
$403.86K
Response Genetics
Feb 06, 2012
Director
Informative Buy
1.50K
$11.00
List of latest transactions for each holding click on a transaction to see Michael Metzger's performance on stock
You May Also Like
Michael Metzger insider profile FAQ
What is the percentage of profitable transactions made by Michael Metzger?
The percentage of profitable transactions made by Michael Metzger is ―.
What is the average return per transaction made by Michael Metzger?
The average return per transaction made by Michael Metzger is ―.
What stocks does Michael Metzger hold?
Michael Metzger holds: TBRA, CTIC, SNDX, RGDXQ stocks.
What was Michael Metzger’s latest transaction?
Michael Metzger latest transaction was an Uninformative Buy of ―.
What was Michael Metzger's most profitable transaction?
Michael Metzger’s most profitable transaction was an Informative Buy of RGDXQ stock on February 6, 2012. The return on the trade was -22.20%.
What is Michael Metzger's role in Tobira Therapeutics?
Michael Metzger's role in Tobira Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.